Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|February 4, 2016
Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patientsLimian Ling, Yuyang Lin, Wenwen Zheng, et al.
Cytotechnology|August 27, 2024
Exosomes from myoblasts induced by hypoxic preconditioning improved ventricular conduction by increasing Cx43 expression in hypothermia ischemia reperfusion heartsTingju Hu, Rui Duan, Hong Gao, et al.
Cell Research|March 22, 2017
Structure and mechanism of a group-I cobalt energy coupling factor transporterZhihao Bao, Xiaofeng Qi, Sen Hong, et al.
Future Oncology (London, England)|June 6, 2014
The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemiaMichael Hallek, Neil E Kay, Anders Osterborg, et al.
Journal for Immunotherapy of Cancer|August 17, 2025
Biomineralized engineered <i>Lactococcus lactis</i>-based in situ vaccination enhances antitumor immunity via sequential activation of chemo-immunotherapyZiqi Chen, Yaohua Ke, Junmeng Zhu, et al.
Ibrain|September 29, 2025
Epigenetic regulation in cognitive impairment: Focus on N6-methyladenosine modification and its potential role in perioperative neurocognitive disordersTing Liu, Xiao-Juan Yang, Lin Zhou, et al.
Plos One|June 5, 2014
Histone deacetylase HDAC4 promotes gastric cancer SGC-7901 cells progression via p21 repressionZhen-Hua Kang, Chun-Yan Wang, Wen-Liang Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase I first-in-human pharmacokinetic and pharmacodynamic study of serdemetan in patients with advanced solid tumorsJosep Tabernero, Luc Dirix, Patrick Schöffski, et al.
Drug Design, Development and Therapy|September 10, 2025
Comparison of EEG Burst Suppression and Hemodynamic Effects Between Remimazolam Tosilate and Etomidate During General Anesthesia Induction: A Retrospective AnalysisYing Cao, Mi Gan, Linling Wan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, et al.
Pageof 6